Welcome to our dedicated page for Axcelis Technologies news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Technologies stock.
Axcelis Technologies Inc. (Nasdaq: ACLS) is a world-leading provider of equipment and services to the semiconductor manufacturing industry. For over 35 years, Axcelis has been a trusted partner for chipmakers globally, delivering cutting-edge solutions and expertise in the critical process of ion implantation. This process is essential for the fabrication of semiconductor chips used in everyday electronics such as smartphones, laptops, cameras, and more.
The company's suite of products includes advanced ion implantation systems, which form transistors that power electronic devices. Axcelis' Purion™ platform is renowned for its flexibility and advanced technology, catering to diverse needs from high current to high energy implants. The Purion Power Series™, particularly, addresses the growing demand in power device applications, including silicon carbide (SiC) technology, crucial for automotive, industrial, and energy applications.
Axcelis also offers comprehensive aftermarket services, including spare parts, equipment upgrades, maintenance, and customer training, ensuring maximum operational efficiency and longevity of its products. The company’s advanced technology center in Beverly, Mass., serves as a hub for innovation, collaborating with industry experts and customers to develop next-generation applications.
Financially robust, Axcelis continues to achieve record performance. In 2023, the company reported a 23% year-over-year growth, with revenues surpassing $1.1 billion. The strong market position is further evidenced by a $1.2 billion backlog at the year's end. Axcelis' strategic focus on the Asia Pacific region, which contributes significantly to its revenue, underscores its global outreach and market adaptability.
Recent achievements highlight Axcelis' leadership and innovation. The company showcased its latest technologies at SEMICON Korea 2024 and announced multiple shipments of its Purion Power Series™ to leading chipmakers worldwide. Axcelis also strengthened its board with new directors, bringing in valuable industry expertise.
As the semiconductor industry evolves, Axcelis remains committed to driving innovation and supporting its customers with state-of-the-art ion implantation solutions, ensuring a bright and technologically advanced future.
Axcelis Technologies reported a strong financial performance in Q3 2022, with revenue of $229.2 million, up from $221.2 million in Q2. Operating profit decreased slightly to $53.2 million, while net income was $40.3 million, or $1.21 per diluted share, down from $44.2 million or $1.32 per diluted share. Gross margin improved to 45.1%. The company also reported a record systems backlog of $1.1 billion and booking of $337.1 million. For Q4 2022, Axcelis expects revenue of $232-240 million and operating profit of $41-45 million.
Axcelis Technologies (Nasdaq: ACLS) announced shipments of its PurionH™ and PurionXE™ implanters to a major analog chip manufacturer in North America. This follows a series of multi-year purchase orders aimed at enhancing the chipmaker's manufacturing capabilities. CEO Mary Puma highlighted the customer's confidence in Axcelis, reflecting strong business relationships.
The company has over 40 years of experience in the semiconductor sector, focusing on high-productivity solutions and support for critical ion implantation processes.
Axcelis Technologies (Nasdaq: ACLS) will release its third quarter 2022 financial results on November 2, 2022, at 4:00 p.m. ET. A follow-up conference call to discuss the results is scheduled for November 3, 2022, at 8:30 a.m. ET. Interested parties can access the call via an audio webcast on the company's website. The company specializes in high-productivity solutions for the semiconductor industry, particularly in the area of ion implantation systems.
Axcelis Technologies, Inc. (NASDAQ: ACLS) announced the qualification of its Purion XEmax high energy ion implant system for production at a leading CMOS image sensor manufacturer. This advancement is expected to enhance image sensor technology and production capabilities, driving growth in the image sensor market. The Purion XEmax is designed for high-performance applications, featuring advanced filtration systems to maintain photodiode quality. This move reflects Axcelis’ commitment to innovation in semiconductor solutions amid increasing demand.
Axcelis Technologies (NASDAQ: ACLS) announced its sponsorship and participation in the International Conference on Ion Implantation Technology 2022, set for September 25-29 in San Diego, CA. This marks over 40 years of Axcelis's involvement in the conference series. The event will focus on advances in ion implantation technologies, featuring presentations on topics such as the Purion H200™ single wafer implanter and advanced angle control solutions. Axcelis aims to address critical challenges in the semiconductor industry through these discussions.
Axcelis Technologies, based in Beverly, Mass, announced its participation in two upcoming investor conferences. The D.A. Davidson Big Sky Technology Summit will occur on August 22-23, 2022, with one-on-one meetings scheduled for August 23rd. Additionally, Axcelis will attend the Needham Virtual 3rd Annual SemiCap and EDA Conference on August 25, 2022, facilitating one-on-one meetings for interested investors. Axcelis has over 40 years of experience in the semiconductor industry, specializing in ion implantation solutions.
Axcelis Technologies (ACLS) reported robust financial results for Q2 2022, achieving $221.2 million in revenue, a rise from $203.6 million in Q1. The operating profit increased to $54.1 million, with net income at $44.2 million or $1.32 per diluted share. Gross margin improved to 44.8%. The company experienced record system bookings of $432.8 million and backlog reaching $869.5 million. For FY 2022, revenue is projected to exceed $875 million, with a gross margin of approximately 42.5%.
Axcelis Technologies (Nasdaq: ACLS) has officially opened its new Axcelis Asia Operations Center in Pyeongtaek-Si, Korea, significantly increasing its manufacturing capacity. The state-of-the-art facility spans over 44,000 square feet and is certified by ISO 45001 for occupational health and safety. Initial shipments commenced in Q1, and the center aims to enhance customer relationships and streamline operations across Asia. This investment is expected to create numerous local jobs in various functions.
Axcelis Technologies (Nasdaq: ACLS) announced robust financial expectations for Q2 2022, projecting revenues exceeding $215 million, a gross margin of approximately 41%, operating profit around $41 million, and earnings per diluted share of about $1.00. The company cites strong demand for ion implantation solutions within the semiconductor sector, with booking levels supporting over $850 million in total revenue for the year. A conference call is scheduled for August 4, 2022, to discuss these results in further detail.
Axcelis Technologies (Nasdaq: ACLS) has announced significant progress in the power device segment with multiple shipments of its Purion H200 Si 200mm and SiC Power Series™ 150mm high current implanters to major power device chipmakers in Asia. These systems are intended for high-volume production in the automotive sector, which is experiencing rapid growth.
Executive Vice President Bill Bintz stated that the power device segment is projected to comprise 30% to 40% of their system sales in 2022, highlighting the company's commitment to support electric vehicle technology through advanced manufacturing solutions.
FAQ
What is the current stock price of Axcelis Technologies (ACLS)?
What is the market cap of Axcelis Technologies (ACLS)?
What does Axcelis Technologies Inc. specialize in?
What are the key products of Axcelis Technologies?
How does Axcelis support its products post-sale?
Where is Axcelis Technologies headquartered?
What financial achievements did Axcelis report for 2023?
What is the significance of the Purion Power Series™?
How does Axcelis collaborate with the semiconductor industry?
What recent strategic moves has Axcelis made?
What upcoming events is Axcelis participating in?
What is the future outlook for Axcelis Technologies?
